Skip to content
  • Home
  • Who we are
  • Clinical research
  • Pharmacovigilance and Drug Safety
  • Regulatory affairs
  • Pharma-Biotech Company
  • Contacts
    • Whistleblowing
GBPHARMA WHT

Archives

GB Pharma has obtained the prestigious UNI/PDR 125:2022 certification for gender equality.

This important milestone demonstrates GB Pharma’s commitment to promoting a fair and inclusive work environment

COMPLIANCE INSIGHTS | Understanding the Regulatory Landscape: the Impact of MDR 2017/745 on Medical Devices

As the medical device industry continues to evolve, so too do the regulatory frameworks governing these critical products.

RISK MANAGEMENT AND MITIGATION | Navigating the Waters of Pharmacovigilance: The Risks and How to Safeguard Your Drug Development Journey

Choosing the right Contract Research Organization (CRO) for your pharmacovigilance services is a critical decision that can shape the success and safety of your drug development journey.

OBSERVATIONAL STUDIES IN CLINICAL RESEARCH | understanding the role of observational studies in clinical research: a comprehensive overview

Observational studies play a pivotal role in the realm of clinical research, offering valuable insights into real-world healthcare practices, disease patterns, treatment outcomes, and more.

EXCITING NEWS | GB Pharma Welcomes New Digital Marketing and Commercial Director!

Stefania Fiordaliso

We are thrilled to announce a significant addition to the GB Pharma family as we warmly welcome Stefania Fiordaliso to our team as Digital Marketing and Commercial Director

Services

  • Clinical Research
  • Medical Devices
  • Marketing Services
  • Regulatory Affairs
  • Pharmacovigilance
  • Drug Safety

Who we are

  • Work with us
  • Contacts
  • Ethical code

Policy

  • Anti-corruption
  • Privacy and Cookie
  • Privacy information
  • Equal Opportunities
  • UNI/Pdr 125:2020
  • Gender Equality

Follow Us

  • Linkedin
Contact Us

Copyright 2025 © All rights Reserved. Powered by VSC